Kiniksa Pharmaceuticals to Present at TD Cowen 46th Annual Health Care Conference
Thursday, February 26, 2026 1 min read
Key Takeaway: Kiniksa Pharmaceuticals will participate in a fireside chat at the TD Cowen 46th Annual Health Care Conference on March 2, 2026. The presentation will be accessible via a live webcast, with a replay available shortly after. This event underscores Kiniksa's focus on improving patient outcomes through novel therapies.
Price reaction · baseline $42.76 (2026-02-25 close) · hit pre-market · clean, no other KNSA news in the window
day 0 close · peak
+1.7%
Market Sentiment Analysis
POSITIVE FACTORS
Kiniksa Pharmaceuticals is actively engaging with investors.
The company will showcase its commitment to addressing unmet medical needs.
The event provides a platform for Kiniksa to highlight its innovative therapies.
Full Press Release Details
LONDON, Feb. 25, 2026 (GLOBE NEWSWIRE) --Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will participate in a fireside chat at the TD Cowen 46thAnnual Health Care Conference on Monday, March 2, 2026 at 3:10 p.m. Eastern Time.
A live webcast of Kiniksa’s presentation will be accessible through the Investors section of the company’s website atwww.kiniksa.com.A replay of the event will also be available on Kiniksa’s website within approximately 48 hours after the event.
About KiniksaKiniksa is a biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating diseases by discovering, acquiring, developing, and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications. Kiniksa’s portfolio of assets is based on strong biologic rationale or validated mechanisms and offers the potential for differentiation. For more information, please visitwww.kiniksa.com.